Athanasiou A, Tennstedt P, Wittig A, Huber R, et al. A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology. PLoS One 2021;16:e0259093.
PMID: 34767586